BMC Cancer Oncology

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors

Rikke Løvendahl Eefsen, Jan Stenvang, Jiri Bartek, Per Pfeiffer, Line Tarpgaard, Susann Theile, Nils Brünner, Dorte L. Nielsen
Springer Nature · 2026-02-16 · DOI 10.1186/s12885-026-15743-7

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →